• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-2 与别嘌醇抑制剂复合物的结构解析:分子动力学模拟和自由能计算。

Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.

机构信息

Dipartimento Farmaco-Chimico, University of Bari Aldo Moro, Bari, Italy.

出版信息

PLoS One. 2011;6(10):e25597. doi: 10.1371/journal.pone.0025597. Epub 2011 Oct 5.

DOI:10.1371/journal.pone.0025597
PMID:21998672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3187794/
Abstract

Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, homeostatic regulation, innate immunity, impaired delivery of pro-apoptotic ligands, and the release and cleavage of cell-surface receptors. Hence, the development of potent and selective inhibitors targeting these enzymes continues to be eagerly sought. In this paper, a number of alloxan-based compounds, initially conceived to bias other therapeutically relevant enzymes, were rationally modified and successfully repurposed to inhibit MMP-2 (also named gelatinase A) in the nanomolar range. Importantly, the alloxan core makes its debut as zinc binding group since it ensures a stable tetrahedral coordination of the catalytic zinc ion in concert with the three histidines of the HExxHxxGxxH metzincin signature motif, further stabilized by a hydrogen bond with the glutamate residue belonging to the same motif. The molecular decoration of the alloxan core with a biphenyl privileged structure allowed to sample the deep S(1)' specificity pocket of MMP-2 and to relate the high affinity towards this enzyme with the chance of forming a hydrogen bond network with the backbone of Leu116 and Asn147 and the side chains of Tyr144, Thr145 and Arg149 at the bottom of the pocket. The effect of even slight structural changes in determining the interaction at the S(1)' subsite of MMP-2 as well as the nature and strength of the binding is elucidated via molecular dynamics simulations and free energy calculations. Among the herein presented compounds, the highest affinity (pIC(50) = 7.06) is found for BAM, a compound exhibiting also selectivity (>20) towards MMP-2, as compared to MMP-9, the other member of the gelatinases.

摘要

基质金属蛋白酶(MMP)是众所周知的生物学靶点,涉及肿瘤进展、内稳态调节、先天免疫、促凋亡配体传递受损以及细胞表面受体的释放和裂解。因此,继续迫切需要开发针对这些酶的有效和选择性抑制剂。在本文中,最初设计用于偏向其他治疗相关酶的一系列别嘌呤醇类化合物经过合理修饰,并成功重新用于在纳摩尔范围内抑制 MMP-2(也称为明胶酶 A)。重要的是,别嘌呤核心首次作为锌结合基团出现,因为它确保了催化锌离子的稳定四面体配位,与 HExxHxxGxxH 金属蛋白酶特征基序的三个组氨酸协同作用,进一步通过与属于同一基序的谷氨酸残基形成氢键来稳定。别嘌呤核心的联苯特权结构的分子修饰允许对 MMP-2 的深 S(1) '特异性口袋进行采样,并将对这种酶的高亲和力与形成氢键网络的机会相关联与口袋底部的 Leu116 和 Asn147 的骨干以及 Tyr144、 Thr145 和 Arg149 的侧链。通过分子动力学模拟和自由能计算阐明了在 MMP-2 的 S(1) '亚位点确定相互作用以及结合的性质和强度中甚至微小结构变化的影响。在所呈现的化合物中,BAM 具有最高的亲和力(pIC(50) = 7.06),它对 MMP-2 表现出选择性(>20),而对 MMP-9,即明胶酶的另一个成员,则没有。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/8740117caf71/pone.0025597.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/c14b8af37fcd/pone.0025597.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/7c54de108dcf/pone.0025597.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/3d2da393ae70/pone.0025597.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/0af3764f795a/pone.0025597.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/f56a0c1076f6/pone.0025597.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/defe7892bb0e/pone.0025597.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/ec32bec15068/pone.0025597.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/72d115f1db9d/pone.0025597.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/8740117caf71/pone.0025597.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/c14b8af37fcd/pone.0025597.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/7c54de108dcf/pone.0025597.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/3d2da393ae70/pone.0025597.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/0af3764f795a/pone.0025597.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/f56a0c1076f6/pone.0025597.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/defe7892bb0e/pone.0025597.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/ec32bec15068/pone.0025597.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/72d115f1db9d/pone.0025597.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2af/3187794/8740117caf71/pone.0025597.g011.jpg

相似文献

1
Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.基质金属蛋白酶-2 与别嘌醇抑制剂复合物的结构解析:分子动力学模拟和自由能计算。
PLoS One. 2011;6(10):e25597. doi: 10.1371/journal.pone.0025597. Epub 2011 Oct 5.
2
Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics.通过分子动力学对一组异羟肟酸酯抑制剂与明胶酶-A进行分子对接研究。
J Comput Aided Mol Des. 2002 Jan;16(1):27-41. doi: 10.1023/a:1016345810973.
3
An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.采用集成计算与实验的方法,获得明胶酶亚家族中 MMP-2 的选择性。
Chembiochem. 2014 Feb 10;15(3):399-412. doi: 10.1002/cbic.201300698. Epub 2014 Jan 21.
4
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).人基质金属蛋白酶-2(MMP-2)强效慢结合抑制的结构基础
J Biol Chem. 2003 Jul 18;278(29):27009-15. doi: 10.1074/jbc.M301139200. Epub 2003 Apr 4.
5
Molecular dynamics simulations of metalloproteinases types 2 and 3 reveal differences in the dynamic behavior of the S1' binding pocket.2型和3型金属蛋白酶的分子动力学模拟揭示了S1'结合口袋动态行为的差异。
Curr Pharm Des. 2007;13(34):3471-5. doi: 10.2174/138161207782794211.
6
Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.鉴定基质金属蛋白酶-2的氨基酸残基,这些残基对于其被β-淀粉样前体蛋白衍生抑制剂选择性抑制至关重要。
J Biol Chem. 2008 Apr 11;283(15):10068-78. doi: 10.1074/jbc.M709509200. Epub 2008 Jan 31.
7
X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. comparison with the latent and active forms of the enzyme.与基于机制的高选择性抑制剂结合的人基质金属蛋白酶-2(MMP-2)的X射线吸收研究。与该酶的潜伏形式和活性形式的比较。
J Biol Chem. 2001 May 18;276(20):17125-31. doi: 10.1074/jbc.M011604200. Epub 2001 Jan 30.
8
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.新型巯基硫化物抑制剂对膜型1基质金属蛋白酶的酶活性及细胞介导的底物裂解的抑制作用。
Biochem J. 2005 Dec 15;392(Pt 3):527-36. doi: 10.1042/BJ20050545.
9
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.与异羟肟酸抑制剂复合的基质金属蛋白酶-2催化结构域的溶液结构和主链动力学
Biochim Biophys Acta. 2002 Jul 29;1598(1-2):10-23. doi: 10.1016/s0167-4838(02)00307-2.
10
Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.明胶酶催化结构域的同源性建模及新型磺胺类抑制剂的对接模拟
J Med Chem. 1999 May 20;42(10):1723-38. doi: 10.1021/jm980514x.

引用本文的文献

1
COP9 signalosome is an essential and druggable parasite target that regulates protein degradation.COP9 信号osome 是一种必需的、可成药的寄生虫靶标,可调节蛋白质降解。
PLoS Pathog. 2020 Sep 22;16(9):e1008952. doi: 10.1371/journal.ppat.1008952. eCollection 2020 Sep.
2
Recent insights into natural product inhibitors of matrix metalloproteinases.基质金属蛋白酶天然产物抑制剂的最新研究进展
Medchemcomm. 2019 Oct 7;10(12):2024-2037. doi: 10.1039/c9md00165d. eCollection 2019 Dec 1.
3
Origin and evolution of protein fold designs inferred from phylogenomic analysis of CATH domain structures in proteomes.

本文引用的文献

1
N-substituted homopiperazine barbiturates as gelatinase inhibitors.N-取代的同哌嗪类巴比妥酸盐作为明胶酶抑制剂。
Bioorg Med Chem. 2011 Aug 15;19(16):4985-99. doi: 10.1016/j.bmc.2011.06.055. Epub 2011 Jun 25.
2
Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.作为强效乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的同二聚体双季铵盐:连接基团和阳离子头对亲和力和选择性影响的系统研究。
J Med Chem. 2011 Apr 28;54(8):2627-45. doi: 10.1021/jm101299d. Epub 2011 Apr 6.
3
Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.
从蛋白质组中 CATH 结构域的系统发生基因组分析推断蛋白质折叠设计的起源和进化。
PLoS Comput Biol. 2013;9(3):e1003009. doi: 10.1371/journal.pcbi.1003009. Epub 2013 Mar 28.
4
An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors.一种整合计算方法来合理化非锌结合 MMP-2 抑制剂的活性。
PLoS One. 2012;7(11):e47774. doi: 10.1371/journal.pone.0047774. Epub 2012 Nov 8.
设计、合成和 4,7-二取代香豆素的咪唑衍生物作为芳香酶抑制剂的生物评价,其对 17-α-羟化酶/C17-20 裂解酶具有选择性。
J Med Chem. 2011 Mar 24;54(6):1613-25. doi: 10.1021/jm101120u. Epub 2011 Feb 22.
4
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.药物银行3.0:药物“组学”研究的综合资源。
Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.
5
Analysis of X-ray structures of matrix metalloproteinases via chaotic map clustering.通过混沌图聚类分析基质金属蛋白酶的 X 射线结构。
BMC Bioinformatics. 2010 Oct 8;11:500. doi: 10.1186/1471-2105-11-500.
6
Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.一类新型强效香豆素单胺氧化酶B抑制剂的发现:7-[(3-氯苄基)氧基]-4-[(甲氨基)甲基]-2H-色烯-2-酮甲磺酸盐(NW-1772)作为一种高效、选择性、可逆且口服活性的单胺氧化酶B抑制剂的研发及生物药理学分析
J Med Chem. 2009 Nov 12;52(21):6685-706. doi: 10.1021/jm9010127.
7
Inhibition of matrix metalloproteinase-2 by PARP inhibitors.聚(ADP-核糖)聚合酶抑制剂对基质金属蛋白酶-2的抑制作用
Biochem Biophys Res Commun. 2009 Oct 2;387(4):646-50. doi: 10.1016/j.bbrc.2009.07.080. Epub 2009 Jul 18.
8
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.基于羟基吡喃酮和羟基噻喃酮的基质金属蛋白酶抑制剂的合成:建立构效关系
Bioorg Med Chem Lett. 2009 Apr 1;19(7):1970-6. doi: 10.1016/j.bmcl.2009.02.044. Epub 2009 Feb 14.
9
Molecular dynamics simulations of the active matrix metalloproteinase-2: positioning of the N-terminal fragment and binding of a small peptide substrate.活性基质金属蛋白酶-2的分子动力学模拟:N端片段的定位及小肽底物的结合
Proteins. 2008 Jul;72(1):50-61. doi: 10.1002/prot.21894.
10
Zinc-binding groups modulate selective inhibition of MMPs.锌结合基团调节基质金属蛋白酶的选择性抑制。
ChemMedChem. 2008 May;3(5):812-20. doi: 10.1002/cmdc.200700290.